Cancer Drugs in China: Unaffordability and Policy Solutions
University of North Carolina at Chapel Hill
Available Online 29 November 2021.
- 10.2991/assehr.k.211120.092How to use a DOI?
- cancer drug; China; affordability; policy; human welfare
The high cost and unaffordability of cancer drugs present serious challenges to treatment access and cancer outcomes. This issue is particularly salient in developing countries, where health care provision is limited and patients are themselves responsible for a large portion of treatment costs. What are the various reasons for the high cost of cancer drugs? How do different countries respond to this challenge differently? What policies are already in place to address this challenge, and what additional issues remain to be addressed in the long term? This paper discusses these topics in the context of China through an economic and public-policy lens and suggests a few long-term solutions.
- © 2021 The Authors. Published by Atlantis Press SARL.
- Open Access
- This is an open access article under the CC BY-NC license.
Cite this article
TY - CONF AU - Yining Liu PY - 2021 DA - 2021/11/29 TI - Cancer Drugs in China: Unaffordability and Policy Solutions BT - Proceedings of the 2021 3rd International Conference on Literature, Art and Human Development (ICLAHD 2021) PB - Atlantis Press SP - 484 EP - 488 SN - 2352-5398 UR - https://doi.org/10.2991/assehr.k.211120.092 DO - 10.2991/assehr.k.211120.092 ID - Liu2021 ER -